Federal Register / Vol. 75, No. 183 / Wednesday, September 22, 2010 / Notices 57805 

oral presentation do not need to register. 

Seating is limited and will be on a firstcome, first-served basis. 

If you would like to make an oral 

presentation during the public session 

on November 17, 2010, you must 

register and provide an abstract of your 

presentation by the close of business on 

October 15, 2010. To speak, submit your 

name, title, business or organization 

affiliation (if applicable), address, 

telephone number, fax number, and 

email address to Sharon Bakayoko (see 

FOR FURTHER INFORMATION CONTACT). 

FDA has included areas of interest in 

section II of this document. Please 

indicate the topic area you wish to 

address in your presentation. FDA will 

do its best to accommodate requests to 

speak. Individuals and organizations 

with common interest are urged to 

consolidate or coordinate their 

presentations and to request time for a 

joint presentation. FDA will determine 

the amount of time allotted to each 

presenter and the approximate time that 

each oral presentation is scheduled to 

begin. Persons registered to make an 

oral presentation should check in at the 

registration desk before the workshop. 

Time will be allowed during the 

scheduled agenda for attendees to ask 

questions of panelists. In addition, we 

strongly encourage electronic or written 

comments to the docket (see section IV 

of this document). 

If you need special accommodations 

because of a disability, please contact 

Sharon Bakayoko at least 7 days before 

the workshop. 

IV. Comments 

Regardless of attendance at the 

workshop, interested persons may 

submit to the Division of Dockets 

Management (see ADDRESSES) either 

electronic or written comments 

regarding this document, including 

suggestions for workshop topics. It is 

only necessary to send one set of 

comments. It is no longer necessary to 

send two copies of mailed comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

V. Electronic Access 

Information about the Safe Use 

Initiative, including the Safe Use 

Report, is available on the Internet at 

http://www.fda.gov/safeuseinitiative. 

Information about the workshop will be 

posted on this Web site when it is 

available. 

VI. Transcripts 

Please be advised that as soon as a 

transcript is available, it will be 

accessible at http://www.fda.gov/ 

safeuseinitiative and http:// 

www.regulations.gov. It may be viewed 

at the Division of Dockets Management 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD. A transcript will 

also be available in either hardcopy or 

on CD–ROM, after submission of a 

Freedom of Information request. Written 

requests are to be sent to the Division 

of Freedom of Information (HFI–35), 

Office of Management Programs, Food 

and Drug Administration, 5600 Fishers 

Lane, rm. 6–30, Rockville, MD 20857. 

Dated: September 16, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–23641 Filed 9–21–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Part D Grant for Coordinated HIV 

Services and Access to Research for 

Women, Infants, Children, and Youth 

Part D Funds Under the Ryan White 

HIV/AIDS Program 

AGENCY: Health Resources and Services 

Administration (HRSA), HHS. 

ACTION: Notice of Non-competitive 

Award of Part D Funds for the 

University of Utah. 

SUMMARY: HRSA will be awarding, noncompetitively, Part D Funds to support 

family-centered primary medical care, 

treatment, and support services (directly 

or through contracts) for women, 

infants, children, and youth with HIV/ 

AIDS, to the University of Utah in order 

to ensure continuity of critical HIV 

medical care and support services, to 

women, infants, children and youth in 

Salt Lake City, Utah and the 

surrounding counties. 

SUPPLEMENTARY INFORMATION: 

Grantee of record: Utah Department of 

Health, Salt Lake City, Utah. 

Intended recipient of the award: 

University of Utah, Salt Lake City, Utah. 

Amount of the award: $350.000 to 

ensure continuity of medical care and 

support services to the target 

population. 

Authority: Section 2671 of the Public 

Health Service Act, 42 U.S.C. 300ff–71. 

CFDA Number: 93.918. 

Project period: August 1, 2010, to July 

31, 2011. The period of support for this 

award is from August 1, 2010, to July 

31, 2011. 

Justification for the Exception to 

Competition 

Funding for critical HIV medical care 

and support services to women, infants, 

children and youth in Salt Lake City, 

Utah and the surrounding areas will be 

continued through a non-competitive 

award to the University of Utah. The 

Utah Department of Health is currently 

contracting all of these services to the 

University of Utah. The University of 

Utah has the clinical, fiscal, and 

administrative infrastructure to 

administer the Part D Grant since it is 

currently the Part C Early Intervention 

Services Grant recipient. This is a 

temporary replacement award, as the 

previous grant recipient serving this 

population notified HRSA that it could 

not continue as the grantee of record 

after July 31, 2010. HRSA’s HIV/AIDS 

Bureau identified the University of Utah 

as the best qualified entity for this 

temporary grant. Since the grant’s 

inception, the Utah Department of 

Health has contracted with the 

University of Utah to provide all Part D 

services, and the University can 

continue to ensure family-centered care 

involving outpatient or ambulatory care 

(directly or through contracts) for 

women, infants, children, and youth 

living with HIV/AIDS. The University is 

able to provide critical services with the 

least amount of disruption to the service 

population while the service area is recompeted. 

This supplement will cover the time 

period from August 1, 2010, through 

July 31, 2011. This service area will be 

included in the upcoming competition 

for the Part D Coordinated HIV Services 

and Access to Research for Women, 

Infants, Children, and Youth for project 

periods starting August, 2011. 

FOR FURTHER INFORMATION CONTACT: Dora 

Ober, by e-mail dober@hrsa.gov, or by 

phone, 301–443–0759. 

Dated: September 15, 2010. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2010–23715 Filed 9–21–10; 8:45 am] 

BILLING CODE 4165–15–P 


emcdonald on DSK2BSOYB1PROD with NOTICES